On the positive side, should they pass Phase II they should be able to negotiate a better deal or even push for phase III. What a dream story, a biotech that has invented treatment for the common cold and the flu!
Downside, I wonder what was the best offer given they were seeking a license partner. BTA management don't sell out cheaply though, they know what their pipeline is worth.
I can't wait to see this trial outcome. Nice work BTA!
BTA Price at posting:
97.0¢ Sentiment: LT Buy Disclosure: Held
